GCP_V1.0
Published by:
Beijing HeMingTang Pharmaceutical Co
Description
本应用为监管方、申办方、CRO、主要研究者、研究者提供临床项目全流程的项目管理和监管追溯功能。
Screenshots
GCP_V1.0 FAQ
-
Is GCP_V1.0 free?
Yes, GCP_V1.0 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is GCP_V1.0 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does GCP_V1.0 cost?
GCP_V1.0 is free.
-
What is GCP_V1.0 revenue?
To get estimated revenue of GCP_V1.0 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Czechia yet.
Ratings History
GCP_V1.0 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
GCP_V1.0 Installs
Last 30 days
GCP_V1.0 Revenue
Last 30 daysGCP_V1.0 Revenue and Downloads
Gain valuable insights into GCP_V1.0 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Beijing HeMingTang Pharmaceutical Co
- Languages
- English, Chinese
- Recent release
- 2108160 (3 years ago )
- Released on
- Nov 18, 2020 (4 years ago )
- Also available in
- Poland, Japan, South Korea, Kuwait, Kazakhstan, Mexico, Malaysia, Nigeria, Netherlands, Norway, Peru, Philippines, Pakistan, Italy, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, United States, Vietnam, South Africa, Egypt, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Chile, China, Czechia, Germany, Denmark, Algeria, United Arab Emirates, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel, India
- Last Updated
- 3 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.